Clinical trial
Post-hepatectomy Adjuvant Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Patients With Preoperative CTC Level ≥2: a Multicenter Randomized Controlled Trial in China
NCT02631499 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-hepatectomy Adjuvant Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Patients With Preoperative CTC Level ≥2: a Multicenter Randomized Controlled Trial in China
- Lead sponsor
- Fudan University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- December 31, 2015
- Completion date
- December 31, 2019
- Enrollment
- 256 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.